Raymond James maintains Market Perform rating on Dave & Buster's stock

Raymond James reiterated its Market Perform rating on Dave & Buster's (PLAY), revising estimates downward with projected comparable sales declines of 8%, 4%, and 3.8% for fiscal Q1, Q2, and full-year 2025, respectively, citing weak traffic data. The revision comes amid a 36% stock decline in the past six months, a Moody's downgrade to B2 with a negative outlook, and price target reductions from UBS and BMO Capital Markets, despite some operational improvements and board member changes. Analysts remain focused on top-line trends, unit growth plans, and the ongoing CEO search, given the company's modest free cash flow and elevated leverage of 3.5x net debt to EBITDA.

Analysis

Raymond James has reiterated its Market Perform rating for Dave & Buster's (NASDAQ: PLAY) while lowering financial estimates due to anticipated weaker performance. Comparable sales estimates have been revised downward, with a projected 8% decline for fiscal Q1 (previously -6.5%), a 4% decline for Q2 2025 (previously -2%), and a 3.8% decrease for the full fiscal year 2025, influenced by third-party traffic data and soft trends at peer entertainment and dining venues. This revision occurs amidst significant stock underperformance, with PLAY shares falling over 36% in the past six months, although InvestingPro analysis indicates the stock might be slightly undervalued. Key investor focus remains on top-line trends and potential changes to unit growth plans, especially given the company's modest free cash flow post-reduction in remodeling plans and its elevated balance sheet leverage, indicated by a net debt to EBITDA ratio around 3.5 times and a debt-to-equity ratio of 23.3x. InvestingPro data also highlights a negative free cash flow yield, underscoring concerns about its debt burden and cash burn. Further compounding these concerns, Moody's Ratings downgraded Dave & Buster's corporate family rating to B2 from B1 and shifted its outlook to negative, citing weak customer traffic and declining consumer confidence. Analyst sentiment is broadly cautious: UBS reduced its price target to $18 from $35 (maintaining Neutral), BMO Capital Markets lowered its target to $30 from $47 (though retaining Outperform, noting some operational improvements despite a Q4 EBITDA miss), and Benchmark maintained a Hold rating. The ongoing search for a new CEO and recent board nominations of Allen R. Weiss and Nathaniel J. Lipman are also critical developments as the company navigates a challenging economic environment and aims to improve operational execution.

Key Decisions for Investors

• Given the deteriorating sales forecasts, high leverage (3.5x net debt/EBITDA, 23.3x debt/equity), negative free cash flow yield, and multiple analyst downgrades, investors should exercise significant caution despite any indications of undervaluation.
• Closely scrutinize the upcoming fiscal first-quarter earnings report, scheduled for June 10, for actual comparable sales performance against the lowered expectations, any updates on unit growth strategies, and management's commentary on cost control and cash flow generation.
• Monitor developments in the ongoing CEO search, as the appointment of new leadership could be a pivotal catalyst for strategic shifts and potentially alter the investment thesis.
• Factor in the recent Moody's credit rating downgrade to B2 with a negative outlook and the substantial price target reductions from analysts like UBS and BMO as indicators of heightened fundamental risks and challenging near-term prospects.